The gastrointestinal tract (GIT) is the largest immune organ and maintains systemic immune
homeostasis in the presence of bacterial challenge. Immune elimination and immune …

Gut microbiome has been increasingly recognized for its influence on a diverse array of
human diseases including cancer, and may also influence the outcome of cancer therapies …

The gut microbiota have long been recognized to play a key role in human health and
disease. Currently, several lines of evidence from preclinical to clinical research have …

Despite the promising advances in novel cancer therapy such as immune checkpoint
inhibitors (ICIs), limitations including therapeutic resistance and toxicity remain. In recent …

Gut microbiota refers to the diverse community of more than 100 trillion microorganisms
residing in our intestines. It is now known that any shift in the composition of gut microbiota …

Cancer treatment has been deeply changed by immunotherapy, achieving unprecedented
improvement in overall and progression-free survival in several advanced and metastatic …

Simple Summary The gut microbiome affects the development of systemic immune response
and it can also impact response to systemic treatments such as immunotherapy and …

The human gastrointestinal (GI) tract harbors gut microbiome, which plays a crucial role in
preserving homeostasis at the intestinal host‐microbial interface. Conversely, specific gut …

Over the last decade, mounting evidence has revealed the key roles of gut microbiota in
modulating the efficacy and toxicity of anticancer drugs, via mechanisms such as …

The commensal microbiota has been implicated in the regulation of a diverse array of
physiological processes, both within the gastrointestinal tract and at distant tissue sites …